IGF-I alters skeletal muscle substrate metabolism and blunts recovery from insulin-induced hypoglycemia

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 4 33-4, 1996, Pages

  Hussain, Mehboob A ^a   Schmitz, Ole ^b   Christiansen, Jens S ^b   Christensen, Niels J ^b   George, K ^b   Alberti, M M ^b   Rudolf Froesch, E ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

catecholamines; cortisol; euglycemic clamp; glucagon; growth hormone; insulin like growth factor I

Indexed keywords

ADRENALIN; FATTY ACID; GLUCAGON; GROWTH HORMONE; HYDROCORTISONE; INSULIN; KETONE BODY; NORADRENALIN; SOMATOMEDIN C;

ADULT; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FOREARM; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPOGLYCEMIA; KETOGENESIS; MALE; MUSCLE METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0029991868     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.4.e545     Document Type: Article

References (30)

1. Bar, R. S., L. C. Harrison, M. Muggeo, P. Gorden, C. B. Kahn, and J. Roth. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv. Int. Med. 24: 23-52, 1988.
2. Barutsch-Marrain, P. R., D. Smith, and R. A. DeFronzo. The effect of growth hormone on glucose metabolism and insulin secretion in man. J. Clin. Endocrinol. Metab. 55: 973-982, 1982.
3. Berelowitz, M., M. Szabo, L. A. Frohman, S. Firestone, and L. Chu. Somatomedin-C mediates growth hormone negative feedback by effects on both hypothalamus and the pituitary. Science Wash. DC 212. 1279-1281, 1981.
4. Boulware, S. D., W. V. Tambourlane, N. J. Rennert, N. Gesundheit, and R. S. Sherwin. Comparison of the metabolic effects of recombinbant human insulin-like growth factor-I and insulin. Dose response relationships in healthy young and middle-aged adults. J. Clin. Invest. 93: 1131-1139, 1994.
5. Christensen, N. J., P. Vestergaard, T. Sorensen, O. J. Rafaelsen. Cerebrospinal fluid adrenaline and noradrenaline in depressend patients. Acta Psychiat. Scand. 61: 178-182, 1980.
6. Christofides, N. D. Glucagon. Radioimmunoassay of Gut Regulatory Peptides, edited by S. R. Bloom and R. G. Long. Philadelphia, PA: Saunders, 1982, p. 74-79.
7. Clemmons, D. R., A. Smith-Banks, and L. E. Underwood. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J. Clin. Endocrinol. Metab. 75: 234-238, 1992.
8. Cooper, K. E., O. G. Edholm, and R. F. Mottram. The blood flow in skin and muscle of the human forearm. J. Physiol. Lond. 128: 258-267, 1955.
9. Davis, M. R., M. Mellman, and H. Shamoon. Physiologic hyperinsulinemia enhances counterregulatory hormone resonpses to hypoglycemia. J. Clin. Endocrinol. Metab. 76: 1383-1385, 1993.
10. 14C glucose. Recent Prog. Horm. Res. 19: 445-488, 1963.
11. DeFronzo, R. A., E. Jacot, E. Jequier, E. Maeder, J. Wahren, and J. P. Felber. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and femoral venous catheterization. Diabetes 30: 1000-1007, 1981.
12. Elia, M., and G. Livesey. Theory and validity of indirect calorimetry during net lipid synthesis. Am. J. Clin. Nutr. 47: 591-607, 1988.
13. Froesch, E. R. Minisymposium on insulin-like growth factor-I. J. Int. Med. 234: 533-577, 1993.
14. Fryburg, D. A. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am. J. Physiol. 267 (Endocrinol Metab. 30): E331-E336, 1994.
15. Harrison, J., P. T. W. Hodson, A. W. Skillen, R. Stappenbeck, L. Agius, and K. G. M. M. Alberti. Blood glucose, lactate, pyruvate, glycerol,β-hydroxybutyrate, and acetoacetate measurements in man using a centrifugal analyser with a fluorometric attachment. J. Clin. Biochem. 26: 141-146, 1988.
16. Hussain, M. A., O. Schmitz, A. Mengel, A. Keller, J. S. Christiansen, J. Zapf, and E. R. Froesch. Insulin-like growth factor-I enhances lipid oxidation, reduces protein oxidation and enhances insulin sensitivity in healthy man. J. Clin Invest. 92. 2249-2256, 1993.
17. Hussain, M. A., O. Schmitz, A. Mengel, A. Keller, J. S. Christiansen, J. Zapf, and E. R. Froesch. Comparison of the effects of growth hormone and insulin-like growth factor-I in growth hormone-deficient subjects. J. Clin. Invest. 94: 1126-1133, 1994.
18. Jacob, R. E., E. Barett, G. Plewe, K. D. Fagin, and R. S. Sherwin. Acute effects of insulin-like growth factor Ion glucose and amino acid metabolism in the awake fasted rat. J. Clin. Invest. 83: 1717-1723, 1989.
19. Kerr, D., W. V. Tambourlane, F. Rife, and R. Sherwin. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. J. Clin. Invest. 91: 141-147, 1993.
20. Kupfer, S. R., L. E. Underwood, R. C. Baxter, and D. R. Clemmons. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by the use of both agents simultaneously. J. Clin. Invest. 91: 391-396, 1993.
21. Laager, R., and U. Keller. Effects of recombinant human insulin-like growth factor-I on counterregulation during acute plasma glucose decrementes in normal and type II (non-insulin dependent) diabetic subjects. Diabetologia 36: 966-971, 1993.
22. Mesiano, S., S. H. Mellon, R. B. Jaffe. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J. Clin. Endocrinol. Metab. 76: 968-976, 1993.
23. Molina, M. J., A. D. Baron, S. V. Edelmann, G. Brechtel, P. Wallace, and J. M. Olefsky. Use of a variable tracer infusion method to determine glucose turnover in humans. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E216-E232, 1990.
24. Randle, P. J., P. B. Garland, C. N. Hales, and E. A. Newsholme. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
25. Rechler, M. M. Insulin-like growth factor binding proteins. In: Vitamins and Hormones. New York: Academic, 1993, vol. 47, p. 1-114.
26. Rennert, N. J., S. Caprio, and R. S. Sherwin. Insulin-like growth factor I inhibits glucose stimulated insulin secretion but does not impair glucose metabolism in normal humans. J. Clin. Endocrinol. Metab. 76: 804-806, 1993.
27. Rizza, R., L. W. Mandarino, and J. E. Gerich. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663-669, 1982.
28. Rosetti, L., D. Smith, G. I. Shulman, D. Papachristou, and R. A. DeFronzo. Correction of hyperglycemia with phlorizin nomalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79: 1510-1515, 1987.
29. Segal, K. R., M. Van Loan, P. I. Fitzgerald, J. A. Hodgson, and T. B. Van Italie. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross validation study. Am. J. Clin. Nutr. 47: 7-14, 1988.
30. Service, F. J. Hypoglycemic disorders. N. Engl. J. Med. 332: 1144-1152, 1995.